| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.005 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |